Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New online treatments could ease prolonged grief

NCT ID NCT06932120

Symptom relief Sponsor: Universitat Jaume I Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two internet-based therapy programs for adults with prolonged grief disorder. One combines online self-help with video sessions with a therapist; the other is self-guided with smartphone check-ins. Both aim to reduce grief symptoms compared to a waiting list. The trial involves 141 participants and lasts 8-12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
internet-based therapy (GROw) with therapist videoconferencing or self-guided with smartphone support
What this could lead to
If successful, this could provide effective, accessible online treatments for prolonged grief disorder, reducing symptoms without needing in-person visits.
What could go wrong
This is a relatively small trial (141 participants) comparing two therapy formats to a waiting list, so results may not apply broadly. The treatments are behavioral, not a cure, and rely on participants' engagement and tech access.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 141 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being at least 18 years old. * Meeting diagnostic criteria for Prolonged Grieft Disorder based on the International Classification of Diseases 11 edition (ICD-11). * Sign an informed consent. * Ability to understand and read Spanish. * Ability to use a computer. * Having an e-mail address. * Having an internet connection and Access to a Smartphone. Exclusion Criteria: * Presence of high risk of suicide. * Presence of axis I severe mental disorder: substance abuse or dependence, psychotic disorder, dementia, bipolar disorder; severe personality disorder or medical illness whose severity or characteristics prevent treatment. * Receiving other psychological treatment during the study. * An increase and/or change in the medication during the study period, in the case of receiving pharmacological treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prolonged grief disorder (PGD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Prolonged Grief Disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prolonged grief disorder (PGD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universitat Jaume I

    RECRUITING

    Castellon, Castellón de La Plana, 12071, Spain

  • Universitat Jaume I

    NOT_YET_RECRUITING

    Castellon, Castellón, 12071, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.